Genotyping Services
ID: 75N95025Q00086Type: Combined Synopsis/Solicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH NIDABethesda, MD, 20892, USA

NAICS

Testing Laboratories and Services (541380)

PSC

MEDICAL- LABORATORY TESTING (Q301)
Timeline
    Description

    The Department of Health and Human Services, through the National Institutes of Health (NIH), is seeking proposals for genotyping services to analyze 1,500 DNA samples related to Alzheimer's Disease and Related Dementias research. The selected contractor will perform microarray genotyping using Illumina Infinium Global Diversity + Neurobooster Arrays, ensuring quality control and timely reporting of results to support the National Institute on Aging's objectives in advancing research in this critical area. Proposals must be submitted electronically by 11:00 A.M. Eastern on December 27, 2024, to Hashim Dasti at hashim.dasti@nih.gov, with the anticipated award being a firm fixed-price purchase order for a period of twelve months after receipt of order. Interested parties should ensure compliance with all applicable federal regulations and provide evidence of their capability to fulfill the requirements outlined in the solicitation.

    Point(s) of Contact
    Files
    Title
    Posted
    This document outlines the representation requirements related to telecommunications and video surveillance services or equipment as mandated by the federal regulation 52.204-24, in line with the John S. McCain National Defense Authorization Act for Fiscal Year 2019. It emphasizes that Offerors must declare whether they provide or use any "covered telecommunications equipment or services" in any contracts or operational systems. The regulations set forth a prohibition against executive agencies procuring equipment or services that utilize covered telecommunications components. The Offerors must also conduct a reasonable inquiry and consult the System for Award Management (SAM) for any excluded parties. Detailed disclosures are required outlining the nature and origin of any such equipment and services involved in their proposals. This provision is aimed at safeguarding national security by preventing the use of potentially compromised telecommunications infrastructure in government contracts and projects. The process enforces accountability and transparency, reinforcing compliance in the government procurement framework.
    The document outlines the representation requirements related to "covered telecommunications equipment or services" for Offerors engaging with the federal government. It defines key terms and mandates that Offerors conduct a thorough review of the System for Award Management (SAM) to identify entities barred from receiving federal awards due to violations concerning covered telecommunications. Offerors are required to declare whether they provide or utilize such telecommunications products or services in their contracts with the government. This representation must be backed by a reasonable inquiry into their offerings. The document concludes with a certification section, requiring the signature of an authorized individual from the organization to validate the representation. This provision is critical in ensuring compliance with federal regulations regarding telecommunications, aimed at safeguarding government contracts from potential security risks associated with certain equipment and services.
    The document outlines terms and conditions related to the acquisition of commercial items by the U.S. Government, providing guidance on resolving inconsistencies within contracts. It establishes a clear order of precedence for applicable documents, starting with the schedule of supplies/services and extending to specifications and other attachments. The addendum discusses commercial supplier agreements, detailing their legal implications and stipulations when engaging with government entities. Key provisions include the binding nature of agreements for the government as the end user, governance under federal law, restrictions on unilateral changes, and limitations on indemnification and audits. It ensures that any conflicts with federal standards are resolved in favor of compliance with government requirements and emphasizes the prohibition of automatic renewals without government consent. Overall, the addendum is crucial for ensuring that both suppliers and the government understand their rights and obligations within commercial transactions, especially in technology-related acquisitions.
    This government file outlines various Federal Acquisition Regulation (FAR) clauses and requirements that contractors must adhere to while engaging in contracts for commercial products and services. The document includes provisions relevant to ethics, whistleblower protections, subcontracting limitations, and employment rights, alongside specific regulations on the use of certain technologies and materials. Key requirements address the prohibition of contracting with entities tied to Kaspersky Lab, the need for small business participation, and maintaining compliance with labor standards. Furthermore, it highlights the importance of safeguarding federal interests, ensuring prompt payments to small businesses, and implementing sustainable practices. The document serves as a comprehensive guide for contractors on legal and regulatory stipulations crucial for federal contracting, pushing for transparency, ethical conduct, and equitable opportunities within government procurement activities. In the context of RFPs and grants, it underscores the intricate landscape of compliance that vendors must navigate to secure contracts and grants successfully.
    The provision 52.222-52 outlines the certification requirements concerning the exemption from the Service Contract Labor Standards for specific contractual services. Offerors must confirm whether their services are regularly sold to non-Governmental clients at established prices and whether service employees spend minimal time (less than 20%) on Government contracts. Additionally, they must use consistent compensation plans for employees across both Government and commercial services. The certification affects whether the Service Contract Labor Standards clause applies to their contract. If an offeror does not certify compliance, specific consequences follow, including the potential exclusion from contract awards. The document underscores the importance of certification compliance within federal procurement processes, facilitating proper contractor classification and ensuring fair labor standards application.
    The document outlines the Invoice and Payment Provisions applicable to federal Purchase Orders, Task or Delivery Orders, and Blanket Purchase Agreements (BPAs), focusing on compliance with the Prompt Payment Act and NIH implementation requirements. Key invoice requirements include detailed documentation such as contractor identification, unique invoice numbers, and the inclusion of the Unique Entity Identifier (UEI) alongside the Federal Taxpayer Identification Number (TIN). Prompt payment timelines stipulate that payments are due within 30 days after receipt of a proper invoice or government acceptance of the delivered services, with specific provisions for perishable goods. Additionally, the document mandates the use of the Department of Treasury's Invoice Processing Platform (IPP) for electronic invoice submissions, with penalties for late payments governed by applicable laws. It emphasizes accelerated payment practices for small business subcontractors and requires Contractors to follow prescribed electronic submission guidelines unless alternate procedures are authorized. Overall, the document serves to ensure orderly and timely payment processes, supporting a transparent and efficient procurement environment within federal contracting.
    Lifecycle
    Title
    Type
    Genotyping Services
    Currently viewing
    Combined Synopsis/Solicitation
    Similar Opportunities
    The Role of Mitochondrial Genetic Variation in Dementia
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified small business sources for a project titled "The Role of Mitochondrial Genetic Variation in Dementia." The objective of this procurement is to obtain laboratory analysis of mitochondrial genetic variation in brain tissue samples from dementia patients, which will aid in understanding the relationship between mitochondrial function and Alzheimer's disease. This initiative is crucial as it aims to explore potential pathways to dementia through the examination of mitochondrial DNA mutations and oxidative capacity in patient samples. Interested contractors must submit their responses by January 2, 2025, to Kevin Alvarez at kevin.alvarez@nih.gov, detailing their capabilities and business size status, as this opportunity is particularly focused on small businesses.
    Single-plex NULISApcr Absolute Quantification Assay of HDGFL2 in Plasma Samples
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is soliciting proposals for the development of a single-plex NULISApcr absolute quantification assay to measure HDGFL2 levels in plasma samples, linked to TDP-43 dysfunction associated with Alzheimer’s Disease and Related Dementias (ADRD). The project aims to establish a biomarker for HDGFL2, which is crucial for advancing research and treatment in neurological disorders. The anticipated contract will be a firm fixed-price purchase order with a performance period of twelve months, and proposals must be submitted electronically to Emily Palombo at emily.palombo@nih.gov by 9:00 a.m. Eastern Daylight Time on December 23, 2024. Interested parties should ensure compliance with all relevant FAR provisions and include necessary certifications in their submissions.
    cDNA-PCR Sequencing Kits for long-read sequencing.
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for the procurement of cDNA-PCR Sequencing Kits for long-read sequencing, as part of a combined synopsis/solicitation. The primary objective is to acquire Promethion Flow Cell packs and sequencing kits to support high-throughput sequencing efforts aimed at advancing research on neurodegenerative diseases, particularly Alzheimer's disease. This procurement is crucial for the Center for Alzheimer’s Disease and Related Dementias (CARD) and is expected to facilitate the identification of causative genes and potential therapeutic targets. Interested vendors must submit their quotations by 5:00 p.m. Eastern Time on December 30, 2024, referencing Solicitation Number 75N95025Q00008, and can direct inquiries to Iris Merscher at iris.merscher@nih.gov or by phone at 301-827-2547.
    Long Sequencing Kits
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) NIDA, is seeking qualified small businesses to provide Long Sequencing Kits as part of a Sources Sought notice. The primary objective of this procurement is to acquire kits that facilitate long read sequencing for analyzing biomarkers related to Alzheimer's Disease and Alzheimer's Disease Related Dementias (AD/ADRD), which are crucial for understanding disease progression and therapeutic efficacy. The kits must meet specific technical requirements, including compatibility with Nanopore PromethION 48 sequencers and the ability to generate substantial sequencing data in real-time. Interested parties must submit their capability statements to Andrea Clay at amcgee@nida.nih.gov by December 31, 2024, at 12:00 PM Eastern Time, as this notice is strictly for research and information purposes and does not obligate the government to award a contract.
    Assay Kits for Lumipulse instrument
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for the procurement of assay kits for the Lumipulse instrument, aimed at quantifying specific biomarkers related to Alzheimer's Disease. The acquisition includes a total of 4,410 assays for biomarkers abeta42, abeta40, and pTau 217, which will be utilized in research involving stored samples from the Baltimore Longitudinal Study of Aging (BLSA) to assess cognitive decline and neurodegeneration. This procurement is critical for advancing Alzheimer’s research and will be awarded as a firm fixed-price purchase order, with quotations due by 5:00 p.m. Eastern Time on January 8, 2025. Interested vendors should contact Iris Merscher at iris.merscher@nih.gov for further details.
    iNDI ALFAtag cell lines for the iPSC Neurodegenetive Disease Initiative (iNDI) project
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified small businesses to provide iNDI ALFAtag cell lines for the iPSC Neurodegenerative Disease Initiative (iNDI) project. The primary objective of this procurement is to generate a collection of up to 230 genetically engineered isogenic cell lines related to Alzheimer's disease and related dementias, which will serve as a national cell repository for the scientific community. These cell lines will be utilized to characterize how genetic mutations affect disease-relevant cell types, with specific requirements for quality control and genetic validation processes. Interested vendors must submit their capability statements by December 27, 2024, at 12:00 PM Eastern Time, to Andrea Clay at amcgee@mail.nih.gov, and should include their company details and relevant qualifications.
    Opera Phenix Plus High-Content Screening System (or equal)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified small businesses to provide an Opera Phenix Plus High-Content Screening System or an equivalent product for the Intramural Center for Alzheimer’s and Related Dementias (CARD). The procurement aims to acquire a high-content imaging system capable of analyzing cellular samples, including organoids and tissue slices, to support research on neurodegenerative diseases. This initiative is critical for advancing the understanding of Alzheimer’s disease and related conditions through the analysis of induced pluripotent stem cells (iPSCs). Interested vendors must submit their capability statements by December 27, 2024, at 5 PM Eastern Time, to Iris Merscher at iris.merscher@nih.gov, ensuring compliance with the specified requirements and guidelines.
    65--Illumina Reagents and Consumables
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Heart, Lung, and Blood Institute (NHLBI), intends to award a non-competitive contract to Illumina, Inc. for the supply of "Illumina Reagents and Consumables" essential for various sequencing and genotyping systems. This procurement is driven by the unique operational needs of NIH-owned systems, as confirmed by market research indicating that only Illumina can provide the proprietary reagents necessary to maintain research integrity and support ongoing studies. The contract performance period is set from September 3, 2025, to September 2, 2030, and interested parties may submit capability statements for review by January 6, 2025; however, this is not a solicitation for proposals. For further inquiries, interested parties can contact Ethan J. Mueller at ethan.mueller@nih.gov or by phone at +1 301 496 2153.
    A--National Gene Vector Biorepository
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is seeking proposals for the National Gene Vector Biorepository (NGVB) to support gene therapy research for the National Heart, Lung, and Blood Institute (NHLBI). The contract aims to provide essential resources and services, including administrative management, core laboratory activities, and compliance with FDA regulations and Good Laboratory Practices (GLP). This initiative is crucial for advancing gene therapy capabilities and ensuring the proper archiving of biological specimens and development of assays. Proposals must be submitted by January 10, 2025, and should include detailed technical and business plans, with specific formatting guidelines and a budget submission required. For further inquiries, interested parties can contact Ethan J. Mueller at ethan.mueller@nih.gov or +1 301 496 2153.
    SOURCES SOUGHT: Mass Spectrometer
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking information from qualified small businesses regarding their capabilities to provide a mass spectrometer system for the iPSC Neurodegenerative Diseases Initiative (INDI) Project. The procurement aims to acquire advanced mass spectrometry equipment that will facilitate the measurement of neurodegeneration-related mutations and their effects on protein networks in disease-relevant cells. This equipment is critical for advancing research in neurodegenerative diseases, particularly within the new Center for Alzheimer’s Disease and Related Dementias (CARD). Interested parties must submit their capability statements to Hashim Dasti at hashim.dasti@nih.gov by December 31, 2024, at 11 AM Eastern Time, adhering to specified formatting guidelines and including relevant business information.